Beltran, Himisha
Harvard Medical School,
United States
2025 Rank: 10183
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 292 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10183 | 9941 |
| Total Cites | 3363 | 3806 |
| H-index | 28 | 31 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 408 | 446 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 809 | 872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1971 | 2122 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.79 |
| Self-Citation Percentage |
11.64%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2024 Rank: 7995
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 253 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7995 | 7332 |
| Total Cites | 3130 | 3567 |
| H-index | 28 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 381 | 430 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 752 | 837 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1919 | 2070 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.72 |
| Self-Citation Percentage |
12.25%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2023 Rank: 8483
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 302 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8483 | 7962 |
| Total Cites | 3301 | 3798 |
| H-index | 29 | 31 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 419 | 475 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 714 | 795 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1949 | 2119 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.79 |
| Self-Citation Percentage |
13.09%
|
|
Beltran, Himisha
Harvard Medical School,
United States
2022 Rank: 9798
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 379 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9798 | 8397 |
| Total Cites | 3247 | 3899 |
| H-index | 31 | 34 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 9 | 10 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 423 | 507 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 719 | 852 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1945 | 2143 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.82 |
| Self-Citation Percentage |
16.72%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2021 Rank: 11381
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 413 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11381 | 10098 |
| Total Cites | 4261 | 5111 |
| H-index | 34 | 39 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 23 | 24 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 597 | 703 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 880 | 1033 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2677 | 2998 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.70 |
| Self-Citation Percentage |
16.63%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2020 Rank: 11955
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 436 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11955 | 11034 |
| Total Cites | 2854 | 3495 |
| H-index | 29 | 31 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 459 | 553 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 572 | 678 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1799 | 2028 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.72 |
| Self-Citation Percentage |
18.34%
|
|